-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H943117
-
鍒嗗瓙寮忥細
C??H?D?N?O
-
--
-
-
|
-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H944587
-
鍒嗗瓙寮忥細
C??H??D??N?O
-
--
-
-
|
-
绱斿害锛�
95%
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H945928
-
鍒嗗瓙寮忥細
C??H??D?N?O
-
--
-
-
|
-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H945932
-
鍒嗗瓙寮忥細
C??H??D?N?O
-
--
-
-
|
-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H945937
-
鍒嗗瓙寮忥細
C??H??D?N?O
-
--
-
-
|
-
绱斿害锛�
98%
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H946632
-
鍒嗗瓙寮忥細
C??H??D?N?O
-
--
-
-
|
-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H947632
-
鍒嗗瓙寮忥細
C??H??D?N?O
-
--
-
-
|
-
绱斿害锛�
95%
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H949915
-
鍒嗗瓙寮忥細
C??H??Cl?N?O
-
--
-
-
|
-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H950210
-
鍒嗗瓙寮忥細
C??H??N?O?S
-
--
-
-
|
N-((5-Hydroxy-6-oxo-4-((2,4,6-trifluorobenzyl)carbamoyl)-1,6-dihydropyrimidin-2-yl)methyl)-1,3,4-oxadiazole-2-carboxamide
N-((5-缇ュ熀-6-姘т唬-4-((2,4,6-涓夋盁鑺愬熀)姘ㄥ熀鐢查叞鍩�)-1,6-浜屾矮鍢у暥-2-鍩�)鐢插熀)-1,3,4-鎯′簩鍞�-2-缇ч叞鑳�
锛堣▊璨ㄤ互鑻辨枃鍚嶇ū鐐烘簴(zh菙n)锛�
-
绱斿害锛�
-
CAS锛�
0
-
MDL锛�
-
鐢�(ch菐n)鍝佺法铏�(h脿o)锛�
H950690
-
鍒嗗瓙寮忥細
C??H??F?N?O
-
--
-
-
|